NHS Finance

09.05.19

NHS to offer landmark multiple sclerosis drug after negotiating manufacturer’s price down

NHS England has reached a deal with a drug manufacturer to provide patients with multiple sclerosis (MS) with a “landmark” drug after NHS bosses pressured the company to lower its price.

Ocrelizumab will be the first available medicine that can modify or change the course of an early primary progressive form of the disease after NHS England struck a deal with manufacturer Roche, paving the way for its approval by NICE.

This comes after NICE rejected the drugs last September due to its high costs, which led to an outcry and a petition to reverse the decision signed by more than 20,000 people, with several MPs taking up the cause.

But NHS England said that after tough negotiations it had secured a commercial in confidence deal with Roche, which is in the range that NICE considers an acceptable use of NHS resources.

The ‘shelf’ price for ocrelizumab is £19,000 a year, but clinical trial results show that it can slow the worsening of disability in people with the condition to the extent that it can delay wheelchair use by seven years.

MS is a lifelong condition which affects the brain and spinal cord, and this new treatment will help those who have primary progressive multiple sclerosis where symptoms steadily increase over a period of months or years without periods of remission.

The innovative deal unlocks the final stage of NICE’s appraisal, and will allow the NHS to provide routine access to the estimated 10,000 to 15,000 people who have the rare form of the disease.

Simon Stevens, chief executive of NHS England, said: “Today the NHS is making a significant advance in the care of people living with multiple sclerosis.

“This latest innovative deal is further proof that companies willing to work flexibly with the NHS can secure a constructive partnership that benefits both patients and taxpayers.”

Access to world-class cutting-edge drugs is part of the NHS Long-Term, with NHS England now having more direct involvement with industry, working with NICE to help find deals for patients and taxpayers.

Previous negotiations between drug manufacturers and NHS England have led to patients getting access to several cancer and hepatitis C drugs after lower prices were agreed, although there is currently an ongoing dispute over the price of Orkambi which is used to treat cystic fibrosis.

Genevieve Edwards, from the MS Society, said: “This is a landmark moment and an incredible victory for the more than 21,000 of us who helped overturn this result.

“We now want to see everyone who could benefit from ocrelizumab being able to access it, with increased support for MS services to make sure this happens.”

Top image: Dominic Lipinski via PA 

 

Enjoying NHE? Subscribe here to receive our weekly news updates or click here to receive a copy of the magazine!

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

latest healthcare news

New £8.4m study launched into long-term impacts of Covid-19

07/07/2020New £8.4m study launched into long-term impacts of Covid-19

The National Institute for Health Research (NIHR) and UK Research and Innovation (UKRI) have launched a major new research study into the long-te... more >
NHS Providers publish guide into NHS digital leadership

07/07/2020NHS Providers publish guide into NHS digital leadership

As part of efforts to help trust leaders build on the momentum achieved during the coronavirus pandemic and support NHS board lead their organisa... more >
Office of Health Economics urges supercharged R&D investment

07/07/2020Office of Health Economics urges supercharged R&D investment

A new report by the Office for Health Economics (OHE) has warned that without immediate action from the Government to “supercharge” p... more >

editor's comment

26/06/2020Adapting and Innovating

Matt Roberts, National Health Executive Editorial Lead. NHE May/June 2020 Edition We’ve been through so much as a health sector and a society in recent months with coronavirus and nothing can take away from the loss and difficulties that we’ve faced but it vital we also don’t disregard the amazing efforts we’ve witnessed. Staff have gone above and beyond, whole hospitals and trusts have flexed virtually at w... read more >

last word

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad, president of the Association of the British Pharmaceutical Industry (ABPI), sits down with National Health Executive as part of our Last Word Q&A series. Would you talk us th... more > more last word articles >

the scalpel's daily blog

NHS at 72: Managing mental health services going forward

03/07/2020NHS at 72: Managing mental health services going forward

Sean Duggan, Chief Executive of the Mental Health Network Let’s take this opportunity to reflect on the amazing achievements of our health system over the past few months. But as we recognise the best of the NHS and its response to the Covid-19 crisis we must not forget that for mental health the peak has yet to come. Covid-19 ... more >
read more blog posts from 'the scalpel' >

comment

NHS England dementia director prescribes rugby for mental health and dementia patients

23/09/2019NHS England dementia director prescribes rugby for mental health and dementia patients

Reason to celebrate as NHS says watching rugby can be good for your mental health and wellbeing. As the best rugby players in the world repr... more >
Peter Kyle MP: It’s time to say thank you this Public Service Day

21/06/2019Peter Kyle MP: It’s time to say thank you this Public Service Day

Taking time to say thank you is one of the hidden pillars of a society. Being on the receiving end of some “thanks” can make communit... more >
Nurses named as least-appreciated public sector workers

13/06/2019Nurses named as least-appreciated public sector workers

Nurses have been named as the most under-appreciated public sector professionals as new research reveals how shockingly under-vauled our NHS, edu... more >
Creating the Cardigan integrated care centre

10/06/2019Creating the Cardigan integrated care centre

Peter Skitt, county director and commissioner for Ceredigion Hywel Dda University Health Board, looks ahead to the new integrated care centre bei... more >

interviews

Matt Hancock says GP recruitment is on the rise to support ‘bedrock of the NHS’

24/10/2019Matt Hancock says GP recruitment is on the rise to support ‘bedrock of the NHS’

Today, speaking at the Royal College of General Practitioners (RCGP) annual conference, Matt Hancock highlighted what he believes to be the three... more >
NHS dreams come true for Teesside domestic

17/09/2019NHS dreams come true for Teesside domestic

Over 20 years ago, a Teesside hospital cleaner put down her mop and took steps towards her midwifery dreams. Lisa Payne has been delivering ... more >
How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

24/10/2018How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

A dedicated national social care service could be a potential solution to surging demand burdening acute health providers over the winter months,... more >
RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

24/10/2018RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

The president of the Royal College of Physicians (RCP) has told NHE that the college’s new headquarters based in Liverpool will become a hu... more >

health service focus

View all News